• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset Realasset
moneycontrol.com

Home » News » IPO » IPO - Issues Open

Dec 07, 2012, 03.19 PM | Source: Moneycontrol.com

Subscribe to CARE IPO for listing gains, says SPA

SPA Research has come out with its report on Credit Analysis and Research Ltd (CARE) IPO. The research firm has recommended investors to subscribe to the issue for listing gains as well as a good long term investment.

Like this story, share it with millions of investors on M3

Subscribe to CARE IPO for listing gains, says SPA

SPA Research has come out with its report on Credit Analysis and Research Ltd (CARE) IPO. The research firm has recommended investors to subscribe to the issue for listing gains as well as a good long term investment.

Post Your Comments

Share Cancel

(more)

, SPA Research |

SPA Research has come out with its report on Credit Analysis and Research (CARE) IPO. The research firm has recommended investors to subscribe to the issue for listing gains as well as a good long term investment.

CARE is the second largest credit rating agency in India in terms of rating revenue. It offers services across a diverse range of instruments and industries and operates broadly through two main verticals 1) Bank Loan Rating and 2) Corporate Debt Rating. Its clients include BFSI, private sector companies, central PSUs, sub-sovereign entities, SME s & micro-finance institutions, among others.

Investment Rationale

Second largest player: CARE is the second largest player in Indian credit rating industry in terms of rating revenues. It is the 3rd rating agency established in India (1993) after CRISIL (1987) & ICRA (1991). Company’s top 3 shareholders are all public sector banks which provide company strong network across banking and other financial intermediaries. Owing to its long years of experience, company has developed strong brand recognition and credibility in the ratings market, gained through years of experience in the ratings business.

Regulations ensure good long term opportunities: Mandatory (Private Placement, Commercial Paper, IPO grading etc) and incentivized rating (Basel II) of credit on the back of stringent risk assessment measures adopted by regulatory institutions ensures continuous long term growth of the credit rating industry.

Diversification into newer products category: CARE has entered in fast growing new product categories such as the SME , education institution grading, real estate ratings and valuation of market linked debentures. CARE has the freedom to enter into overseas markets as its major shareholders do not have the same business out of India, unlike CRISIL and ICRA.

Revival in GDP growth rate would boost rating business: Demand for rating services is driven by overall capital mobilization in the economy which is linked with economic growth that fuels demand for both capital and operational related funding. Planning commission’s target of 8.2% GDP growth rate for the XIIth Five Year Plan (2012-2017) requires estimated doubling of investment in infrastructure that would boost the demand for capital and thus ratings.

Strong Financials: CARE registered robust revenue and PAT CAGR of 38% and 44% in last four years. CARE is a debt free company with cash and cash equivalent of INR 3,375mn, as of Sep 2012, which translates into 118/share. Company generates high free cash flow (FY12 FCF/PAT is 78%) and RoNW of 34%.

Valuation & Recommendation: We are optimistic on the huge long term opportunities for the credit rating sector on the back of development in debt market which is at nascent stage in India. CARE, being one of the largest players in the industry is positioned strongly on back of years of rating experience across various industries along with high brand recognition and strong industry network. On the valuation front, at upper band, stock is available at 21.5x annualized H1FY13 EPS. Historically, industry PE has oscillated between 20x-30x. CARE, however, is more comparable to ICRA in terms of size but outscores in terms of operating margins and CAGR over the last 4 years which has been 38% vis-à-vis 20% for ICRA. Hence, it should command better multiples enjoyed by ICRA. We recommend SUBSCRIBE to the issue for listing gains as well as a good long term investment.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click here

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Subscribe to CARE IPO for listing gains, says SPA

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login